Community Health Assessment Program in the Philippines (CHAP-P)
NCT ID: NCT03481335
Last Updated: 2021-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5229 participants
INTERVENTIONAL
2018-06-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Health Awareness Program (CHAP) in Subsidized Social Housing
NCT03549845
Community-based E-Health Program for Older Adults Living with Chronic Diseases
NCT04560296
Supporting Healthy Aging by Peer Education and Support
NCT02745275
Evaluating the Effect of Neighborhood Environments on Cardiovascular Risk Factors
NCT00361673
The Ebeltoft Health Promotion Project
NCT00145782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The CHAP-P intervention consists of initial and follow-up sessions where trained local volunteers (Barangay Health Workers, or BHWs) take physical measurements (blood pressure, height, weight, waist circumference) and facilitate a diabetes risk survey; based on these findings, they provide education, materials, and referrals to local health resources as needed.
The participant groups in this evaluation include those that attend CHAP-P sessions, randomly selected community members that provide consent for a survey and HbA1c testing, and community members and BHWs/other Lead Local Organization staff who provide consent for focus groups and interviews.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Community
Intervention communities (barangays) will receive the intervention (CHAP-P sessions).
CHAP-P Sessions
Residents of intervention communities (barangays) aged 40+ are openly invited to attend CHAP-P sessions. At CHAP-P sessions, trained local volunteers (Barangay Health Workers, or BHWs) collect consent, measure blood pressure, collect other physical measurements, and conduct a survey to determine clients' risk of diabetes. Based on the findings, BHWs provide education and/or referrals. CHAP-P sessions are held twice a month, and clients are encouraged to continuing attending for ongoing follow-up and monitoring.
Control Community
Control communities (barangays) will receive care as usual.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CHAP-P Sessions
Residents of intervention communities (barangays) aged 40+ are openly invited to attend CHAP-P sessions. At CHAP-P sessions, trained local volunteers (Barangay Health Workers, or BHWs) collect consent, measure blood pressure, collect other physical measurements, and conduct a survey to determine clients' risk of diabetes. Based on the findings, BHWs provide education and/or referrals. CHAP-P sessions are held twice a month, and clients are encouraged to continuing attending for ongoing follow-up and monitoring.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Resident of community
\- Must be a BHW or other LLO staff who is participating in the CHAP-P Intervention
Exclusion Criteria
* Resident of a different community
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ateneo de Zamboanga University
OTHER
Université de Montréal
OTHER
Global Alliance for Chronic Diseases (GACD)
OTHER
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
International Development Research Centre, Canada
OTHER_GOV
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gina Agarwal, MBBS, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Fortunato Cristobal, MD, MPH, MHPEd
Role: PRINCIPAL_INVESTIGATOR
Ateneo de Zamboanga University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ateneo de Zamboanga University
Zamboanga City, Zamboanga Del Sur, Philippines
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Agarwal G, Angeles RN, Dolovich L, Kaczorowski J, Gaber J, Guenter D, Arnuco FD, Lam HY, Thabane L, O'Reilly D, Agbulos RM, Arciaga RS, Barrera J, Gregorio E, Halili S Jr, Jalani N, Cristobal F. The Community Health Assessment Program in the Philippines (CHAP-P) diabetes health promotion program for low- to middle-income countries: study protocol for a cluster randomized controlled trial. BMC Public Health. 2019 Jun 3;19(1):682. doi: 10.1186/s12889-019-6974-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
231837
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
107826-001
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
4303
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.